TY - JOUR
T1 - Lessons learned from newborn screening for critical congenital heart defects
AU - Oster, Matthew E.
AU - Aucott, Susan W.
AU - Glidewell, Jill
AU - Hackell, Jesse
AU - Kochilas, Lazaros
AU - Martin, Gerard R.
AU - Phillippi, Julia
AU - Pinto, Nelangi M.
AU - Saarinen, Annamarie
AU - Sontag, Marci
AU - Kemper, Alex R.
N1 - Publisher Copyright:
© Copyright 2016 by the American Academy of Pediatrics.
PY - 2016/5
Y1 - 2016/5
N2 - Newborn screening for critical congenital heart defects (CCHD) was added to the US Recommended Uniform Screening Panel in 2011. Within 4 years, 46 states and the District of Columbia had adopted it into their newborn screening program, leading to CCHD screening being nearly universal in the United States. This rapid adoption occurred while there were still questions about the effectiveness of the recommended screening protocol and barriers to follow-up for infants with a positive screen. In response, the Centers for Disease Control and Prevention partnered with the American Academy of Pediatrics to convene an expert panel between January and September 2015 representing a broad array of primary care, neonatology, pediatric cardiology, nursing, midwifery, public health, and advocacy communities. The panel's goal was to review current practices in newborn screening for CCHD and to identify opportunities for improvement. In this article, we describe the experience of CCHD screening in the United States with regard to: (1) identifying the target lesions for CCHD screening; (2) optimizing the algorithm for screening; (3) determining state-level challenges to implementation and surveillance of CCHD; (4) educating all stakeholders; (5) performing screening using the proper equipment and in a cost-effective manner; and (6) implementing screening in special settings such as the NICU, out-of-hospital settings, and areas of high altitude.
AB - Newborn screening for critical congenital heart defects (CCHD) was added to the US Recommended Uniform Screening Panel in 2011. Within 4 years, 46 states and the District of Columbia had adopted it into their newborn screening program, leading to CCHD screening being nearly universal in the United States. This rapid adoption occurred while there were still questions about the effectiveness of the recommended screening protocol and barriers to follow-up for infants with a positive screen. In response, the Centers for Disease Control and Prevention partnered with the American Academy of Pediatrics to convene an expert panel between January and September 2015 representing a broad array of primary care, neonatology, pediatric cardiology, nursing, midwifery, public health, and advocacy communities. The panel's goal was to review current practices in newborn screening for CCHD and to identify opportunities for improvement. In this article, we describe the experience of CCHD screening in the United States with regard to: (1) identifying the target lesions for CCHD screening; (2) optimizing the algorithm for screening; (3) determining state-level challenges to implementation and surveillance of CCHD; (4) educating all stakeholders; (5) performing screening using the proper equipment and in a cost-effective manner; and (6) implementing screening in special settings such as the NICU, out-of-hospital settings, and areas of high altitude.
UR - http://www.scopus.com/inward/record.url?scp=84969834735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84969834735&partnerID=8YFLogxK
U2 - 10.1542/peds.2015-4573
DO - 10.1542/peds.2015-4573
M3 - Article
C2 - 27244826
AN - SCOPUS:84969834735
SN - 0031-4005
VL - 137
JO - Pediatrics
JF - Pediatrics
IS - 5
M1 - e20154573
ER -